Publication Information

{'id': 'https://openalex.org/W2161112963', 'doi': 'https://doi.org/10.2174/13816128113196660764', 'title': 'Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC', 'display_name': 'Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC', 'publication_year': 2014, 'publication_date': '2014-06-25', 'ids': {'openalex': 'https://openalex.org/W2161112963', 'doi': 'https://doi.org/10.2174/13816128113196660764', 'mag': '2161112963', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/24138713'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.2174/13816128113196660764', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S55674637', 'display_name': 'Current Pharmaceutical Design', 'issn_l': '1381-6128', 'issn': ['1381-6128', '1873-4286'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320079', 'host_organization_name': 'Bentham Science Publishers', 'host_organization_lineage': ['https://openalex.org/P4310320079'], 'host_organization_lineage_names': ['Bentham Science Publishers'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5029922900', 'display_name': 'Paolo Maione', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Paolo Maione', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032078755', 'display_name': 'Antônio Rossi', 'orcid': 'https://orcid.org/0000-0003-3295-0345'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Antonio Rossi', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045871378', 'display_name': 'Marianna Bareschino', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Marianna Bareschino', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110456595', 'display_name': 'Paola Sacco', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Paola Sacco', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055316467', 'display_name': 'Clorinda Schettino', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Clorinda Schettino', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037193805', 'display_name': 'Francesca Casaluce', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Francesca Casaluce', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103381163', 'display_name': 'Assunta Sgambato', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Assunta Sgambato', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5045384053', 'display_name': 'Cesare Gridelli', 'orcid': 'https://orcid.org/0000-0003-1069-597X'}, 'institutions': [{'id': 'https://openalex.org/I4210111929', 'display_name': 'Azienda Ospedaliera S.Giuseppe Moscati', 'ror': 'https://ror.org/021jxzw96', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210111929']}], 'countries': ['IT'], 'is_corresponding': True, 'raw_author_name': 'Cesare Gridelli', 'raw_affiliation_strings': ['Division of Medical Oncology, “S.G. Moscati” Hospital, Contrada Amoretta - 83100 Avellino Italy.,Italy'], 'affiliations': [{'raw_affiliation_string': 'Division of Medical Oncology, “S.G. Moscati” Hospital, Contrada Amoretta - 83100 Avellino Italy.,Italy', 'institution_ids': ['https://openalex.org/I4210111929']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5045384053'], 'corresponding_institution_ids': ['https://openalex.org/I4210111929'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.138, 'has_fulltext': False, 'cited_by_count': 8, 'citation_normalized_percentile': {'value': 0.2864, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 84, 'max': 85}, 'biblio': {'volume': '20', 'issue': '24', 'first_page': '3894', 'last_page': '3900'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.9916, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.9916, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13561', 'display_name': 'Chemical Reactions and Isotopes', 'score': 0.9327, 'subfield': {'id': 'https://openalex.org/subfields/3003', 'display_name': 'Pharmaceutical Science'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9312, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/afatinib', 'display_name': 'Afatinib', 'score': 0.95043063}, {'id': 'https://openalex.org/keywords/egfr-inhibitors', 'display_name': 'EGFR Inhibitors', 'score': 0.5671195}, {'id': 'https://openalex.org/keywords/erlotinib-hydrochloride', 'display_name': 'Erlotinib Hydrochloride', 'score': 0.4602491}], 'concepts': [{'id': 'https://openalex.org/C2778087573', 'wikidata': 'https://www.wikidata.org/wiki/Q418369', 'display_name': 'Erlotinib', 'level': 4, 'score': 0.9728248}, {'id': 'https://openalex.org/C2780580887', 'wikidata': 'https://www.wikidata.org/wiki/Q417824', 'display_name': 'Gefitinib', 'level': 4, 'score': 0.9722188}, {'id': 'https://openalex.org/C2780586478', 'wikidata': 'https://www.wikidata.org/wiki/Q4688818', 'display_name': 'Afatinib', 'level': 5, 'score': 0.95043063}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7079423}, {'id': 'https://openalex.org/C2779438470', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'Epidermal growth factor receptor', 'level': 3, 'score': 0.7000594}, {'id': 'https://openalex.org/C2776256026', 'wikidata': 'https://www.wikidata.org/wiki/Q47912', 'display_name': 'Lung cancer', 'level': 2, 'score': 0.6390344}, {'id': 'https://openalex.org/C2777506169', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'EGFR inhibitors', 'level': 4, 'score': 0.5671195}, {'id': 'https://openalex.org/C42362537', 'wikidata': 'https://www.wikidata.org/wiki/Q87099740', 'display_name': 'Tyrosine kinase', 'level': 3, 'score': 0.49102926}, {'id': 'https://openalex.org/C2909325608', 'wikidata': 'https://www.wikidata.org/wiki/Q418369', 'display_name': 'Erlotinib Hydrochloride', 'level': 5, 'score': 0.4602491}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.4585438}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.44370705}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.33080828}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.32714897}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.26842198}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.10173741}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D018450', 'descriptor_name': 'Disease Progression', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.2174/13816128113196660764', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S55674637', 'display_name': 'Current Pharmaceutical Design', 'issn_l': '1381-6128', 'issn': ['1381-6128', '1873-4286'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320079', 'host_organization_name': 'Bentham Science Publishers', 'host_organization_lineage': ['https://openalex.org/P4310320079'], 'host_organization_lineage_names': ['Bentham Science Publishers'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/24138713', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.83, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3167107489', 'https://openalex.org/W3042289395', 'https://openalex.org/W3000070469', 'https://openalex.org/W2979585789', 'https://openalex.org/W2779592308', 'https://openalex.org/W2424009759', 'https://openalex.org/W2186047679', 'https://openalex.org/W2174769990', 'https://openalex.org/W2161112963', 'https://openalex.org/W2065683203'], 'abstract_inverted_index': {'The': [0], 'epidermal': [1], 'growth': [2], 'factor': [3], 'receptor': [4], '(EGFR)': [5], 'is': [6], 'among': [7], 'the': [8, 13, 50, 57, 94, 100, 115, 129, 133, 138, 156], 'most': [9, 134], 'important': [10], 'targets': [11], 'in': [12, 114, 137], 'treatment': [14, 76, 117, 139], 'of': [15, 70, 75, 83, 93, 118, 140, 158], 'advanced': [16, 141], 'non-small': [17], 'cell': [18, 36], 'lung': [19, 37, 121], 'cancer': [20], '(NSCLC).': [21], 'Erlotinib': [22], 'and': [23, 53, 90, 105, 126, 147], 'gefitinib,': [24], 'two': [25], 'small': [26], 'molecules,': [27], 'are': [28, 42, 128], 'reversible': [29, 112, 151], 'EGFR': [30, 40, 62, 119, 160], 'tyrosine': [31], 'kinase': [32], 'inhibitors': [33, 113, 161], '(TKIs).': [34], 'Non-small': [35], 'cancers': [38], 'with': [39, 49, 59, 77, 132], 'mutations,': [41], 'characterized': [43], 'by': [44], 'excellent': [45], 'responses': [46], 'when': [47], 'treated': [48], 'EGFR-TKIs': [51, 86, 131], 'gefitinib': [52, 78, 104], 'erlotinib.': [54, 80], 'However,': [55, 153], 'all': [56], 'patients': [58], 'tumors': [60], 'harbouring': [61], 'mutations': [63], 'experience': [64], 'disease': [65], 'progression': [66], 'after': [67, 148], 'a': [68], 'median': [69], '10': [71], 'to': [72, 103, 150, 154, 163], '14': [73], 'months': [74], 'or': [79, 107], 'A': [81], 'group': [82], 'new': [84], 'generation': [85], 'irreversibly': [87], 'inhibit': [88], 'EGFR-TK': [89], 'represent': [91], 'one': [92], 'strategies': [95], 'that': [96], 'may': [97], 'potentially': [98], 'overcome': [99], 'acquired': [101], 'resistance': [102, 149], 'erlotinib': [106], 'achieve': [108], 'better': [109], 'outcomes': [110], 'than': [111], 'first-line': [116], 'mutant': [120], 'cancers.': [122], 'Afatinib': [123], '(BIBW': [124], '2992)': [125], 'PF299804': [127], 'irreversible': [130, 159], 'relevant': [135], 'data': [136], 'NSCLC,': [142], 'as': [143], 'primary': [144], 'EGFR-targeted': [145], 'therapy': [146], 'EGFR-TKIs.': [152], 'date,': [155], 'role': [157], 'remains': [162], 'be': [164], 'defined.': [165]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2161112963', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}], 'updated_date': '2024-12-12T01:08:07.094108', 'created_date': '2016-06-24'}